MEDICUS Engineering is a reputable and innovative brand that specializes in the development, production, and sales of medical devices. Established in 2001, the company has been dedicated to research and development, resulting in a portfolio of cutting-edge products that have been clinically validated and patented. One of their groundbreaking offerings is the Vagus Test Kit, a diagnostic device that is revolutionizing the screening of Cardiovascular Autonomic Neuropathy (CAN), a common complication in diabetes.

This device, which is currently used by over 20 hospitals in Scandinavia, UK, and France, is the only one recommended for large-scale screening and takes only 5-8 minutes to administer. With a clear pathway to FDA 510(k) approval and reimbursement already in place, the Vagus Test Kit is making a significant impact in the medical field. In addition to their CAN screening device, MEDICUS Engineering also offers PreHypo, a clinically validated and patented software algorithm that predicts hypoglycemia in patients with diabetes.

This digital solution has demonstrated superior performance and has the potential to save lives and reduce emergency hospital admissions. Furthermore, MEDICUS Engineering addresses the pressing issue of pressure ulcers with reQbo ApS's innovative product, Q-Scale. This digital application utilizes machine learning to identify patients at risk of developing pressure ulcers, surpassing the golden standard in predictability and providing hospitals with important documentation to prevent malpractice lawsuits.

Committed to quality, MEDICUS Engineering's quality management system adheres to ISO 13485 standards, ensuring their products meet the highest quality and safety requirements. With a focus on innovation, clinical validation, and patented technologies, MEDICUS Engineering is at the forefront of medical device development, offering groundbreaking solutions that positively impact patient care and healthcare outcomes